In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

Earlier this year, researchers of Brigham and Women’s Hospital Harvard Medical School looked at clinical trials to show how six biologics, in particular, improve lung function; cut down on steroid use ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

哮喘和慢性阻塞性肺病（COPD）是常见且致命的呼吸道疾病，每年夺走全球数百万人生命。然而，急性发作时治疗50年来几乎没有进步。近期伦敦国王学院（King′s College London）发表在《柳叶刀呼吸医学》（The Lancet ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

For the study, the investigators randomised people at high risk of asthma or COPD attack into three groups, one receiving benralizumab injection and dummy tablets, one receiving standard of care ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Benralizumab is already used in the most severe cases, but the latest research suggests it could be used routinely for around two million attacks in the UK each year ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Discover how benralizumab offers superior outcomes for eosinophilic asthma and COPD exacerbations, outperforming steroids in ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...